The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of ...

The recent publication of a research paper on a drug trial has given hope to millions of patients with chronic hepatitis B ...

A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...

There is currently no known cure for hepatitis B virus (HBV) infection, and HBV remains a major public health burden in the United States. The US Department of Health and Human Services has ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

A phase I trial published in Lancet Gastroenterology & Hepatology found that imdusiran, an investigational small interfering ...

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...